MediXall Group, Inc. (MDXL)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MediXall Group, Inc. (MDXL) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Die Aktie erzielt 60/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 15. März 2026MediXall Group, Inc. (MDXL) Gesundheitswesen & Pipeline-Uebersicht
MediXall Group, Inc. develops and operates the Health Karma platform, a healthcare marketplace connecting consumers with medical and wellness services. Focusing on improving healthcare accessibility and decision-making, the company targets individuals, employer groups, and third-party administrators within the evolving healthcare information services sector.
Investmentthese
MediXall Group, Inc. presents a high-risk, high-reward investment opportunity within the healthcare information services sector. The company's Health Karma platform aims to capitalize on the growing demand for accessible and transparent healthcare solutions. However, with a market capitalization of $0.00B and a negative profit margin of -1474.8%, the company faces significant financial challenges. A key value driver is the potential for Health Karma to gain traction among individuals, employer groups, and third-party administrators seeking integrated medical and wellness services. Growth catalysts include expanding the platform's service offerings and increasing its user base. Potential risks include intense competition from established players, the need for substantial capital to scale operations, and the volatile nature of OTC markets. Investors should carefully consider these factors before investing.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.01 reflects the company's current lack of profitability.
- Profit margin of -1474.8% highlights substantial operational inefficiencies and the need for significant cost management.
- Gross margin of 23.6% suggests potential for profitability if operational costs are effectively managed.
- Beta of 274.99 indicates extremely high volatility compared to the overall market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Innovative Health Karma platform.
- Focus on consumer empowerment in healthcare.
- Potential for partnerships with healthcare providers.
Schwaechen
- Limited market capitalization and financial resources.
- Negative profit margin and lack of profitability.
- High beta indicating significant volatility.
Katalysatoren
- Upcoming: Expansion of services offered on the Health Karma platform.
- Upcoming: Acquisition of new employer group clients.
- Ongoing: Strategic partnerships with healthcare providers.
- Ongoing: Geographic expansion within the United States.
- Ongoing: Implementation of data analytics for personalization.
Risiken
- Potential: Intense competition from established players in the healthcare information services industry.
- Potential: Regulatory changes impacting the healthcare industry.
- Ongoing: Need for significant capital to scale operations and achieve profitability.
- Ongoing: Limited liquidity due to trading on the OTC market.
- Potential: Negative profit margin and lack of profitability.
Wachstumschancen
- Expansion of Health Karma Platform: MediXall can grow by expanding the services offered on its Health Karma platform. Integrating telehealth services, prescription management, and remote patient monitoring could attract a larger user base. The telehealth market alone is projected to reach $55.6 billion by 2027. This expansion requires strategic partnerships and technological development, with a timeline of 1-2 years for significant implementation.
- Targeting Employer Groups: MediXall can focus on acquiring employer groups as clients for the Health Karma platform. Offering customized wellness programs and healthcare navigation tools to companies can drive revenue growth. The corporate wellness market is estimated at $56.7 billion globally. Securing contracts with medium to large-sized employers within the next 1-3 years could provide a stable revenue stream.
- Strategic Partnerships with Healthcare Providers: Forming partnerships with hospitals, clinics, and independent healthcare providers can expand the reach of the Health Karma platform. Integrating provider services and offering bundled healthcare packages can attract more consumers. The healthcare provider market is vast, with opportunities for collaboration across various specialties. Establishing key partnerships within the next year is crucial for expanding service offerings.
- Geographic Expansion: MediXall can expand its operations beyond its current base in Florida to other states in the United States. Targeting regions with high healthcare costs and a growing demand for digital health solutions can drive user acquisition. The US healthcare market is the largest in the world, offering significant opportunities for growth. A phased expansion approach over the next 2-3 years can mitigate risks and ensure effective market penetration.
- Data Analytics and Personalization: Leveraging data analytics to personalize the user experience on the Health Karma platform can improve engagement and retention. Offering customized healthcare recommendations and personalized wellness plans can attract and retain users. The data analytics market in healthcare is growing rapidly, driven by the need for improved patient outcomes and cost efficiency. Implementing advanced analytics within the next year can provide a competitive advantage.
Chancen
- Expansion into telehealth and remote patient monitoring.
- Acquisition of employer groups as clients.
- Geographic expansion within the United States.
Risiken
- Intense competition from established players.
- Regulatory changes in the healthcare industry.
- Need for significant capital to scale operations.
Wettbewerbsvorteile
- First-mover advantage in creating a comprehensive healthcare marketplace.
- Proprietary Health Karma platform with integrated services.
- Potential for network effects as more users and providers join the platform.
Ueber MDXL
MediXall Group, Inc., established in 1998 and based in Fort Lauderdale, Florida, operates in the healthcare information services sector. The company develops and manages the Health Karma platform, a healthcare marketplace designed to facilitate how consumers learn about, decide on, and pay for healthcare services. Health Karma aims to complement the relationships patients have with their trusted doctors by providing a centralized platform for accessing medical and wellness services. The platform caters to a diverse range of users, including individuals, employer groups, and third-party administrators. MediXall's core mission is to enhance the consumer healthcare experience by improving transparency, accessibility, and convenience. The company focuses on integrating technology to streamline healthcare interactions and empower consumers to make informed decisions about their health and wellness needs. MediXall Group, Inc. operates primarily within the United States, focusing on expanding the reach and functionality of its Health Karma platform to capture a larger share of the healthcare information services market.
Was das Unternehmen tut
- Develops and operates the Health Karma healthcare marketplace platform.
- Connects consumers with medical and wellness services.
- Facilitates informed decision-making about healthcare options.
- Provides a platform for learning about and paying for healthcare services.
- Offers services to individuals, employer groups, and third-party administrators.
- Aims to complement relationships with trusted doctors.
Geschaeftsmodell
- Generates revenue through subscriptions from individuals and employer groups.
- Partnerships with healthcare providers for service integration.
- Potential for revenue sharing from transactions on the Health Karma platform.
Branchenkontext
MediXall Group, Inc. operates within the healthcare information services industry, a sector experiencing growth due to increasing demand for digital health solutions and greater consumer involvement in healthcare decisions. The market is competitive, with established players like ABMT (ABIOMED, Inc.) and HSMD (HealthStream, Inc.) offering various healthcare technology solutions. MediXall's Health Karma platform aims to differentiate itself by providing a comprehensive marketplace for medical and wellness services. The industry is characterized by technological innovation, evolving regulatory landscapes, and a focus on improving patient outcomes and reducing healthcare costs.
Wichtige Kunden
- Individuals seeking accessible healthcare information and services.
- Employer groups looking to offer wellness programs to employees.
- Third-party administrators managing healthcare benefits.
Finanzdaten
Chart & Info
MediXall Group, Inc. (MDXL) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer MDXL verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer MDXL.
Kursziele
Wall-Street-Kurszielanalyse fuer MDXL.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von MDXL auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Travis H. Jackson
CEO
Travis H. Jackson serves as the CEO of MediXall Group, Inc., leading a team of seven employees. His background includes experience in managing and developing healthcare-related ventures. He is responsible for the strategic direction and operational execution of the company's Health Karma platform. Jackson's leadership focuses on driving innovation and expanding the company's reach within the healthcare information services market.
Erfolgsbilanz: Under Travis H. Jackson's leadership, MediXall Group, Inc. has focused on developing and launching the Health Karma platform. Key milestones include securing partnerships with healthcare providers and expanding the platform's service offerings. Jackson's strategic decisions aim to position the company as a key player in the evolving healthcare marketplace.
MDXL OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that MediXall Group, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure due to OTC listing.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement compared to listed companies.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their experience.
- Review the company's business plan and growth strategy.
- Evaluate the competitive landscape and the company's market position.
- Check for any legal or regulatory issues.
- Determine the company's capital structure and funding needs.
- Consult with a financial advisor.
- Operation of the Health Karma platform.
- Partnerships with healthcare providers (if any).
- Presence of a management team and employees.
- Company incorporation and registration.
- Publicly available information (press releases, website).
MediXall Group, Inc. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for MDXL?
MediXall Group, Inc. (MDXL) currently holds an AI score of 60/100, indicating moderate score. Key strength: Innovative Health Karma platform.. Primary risk to monitor: Potential: Intense competition from established players in the healthcare information services industry.. This is not financial advice.
How frequently does MDXL data refresh on this page?
MDXL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MDXL's recent stock price performance?
Recent price movement in MediXall Group, Inc. (MDXL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative Health Karma platform.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider MDXL overvalued or undervalued right now?
Determining whether MediXall Group, Inc. (MDXL) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying MDXL?
Before investing in MediXall Group, Inc. (MDXL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MDXL to a portfolio?
Potential reasons to consider MediXall Group, Inc. (MDXL) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Innovative Health Karma platform.. Additionally: Focus on consumer empowerment in healthcare.. The AI-driven MoonshotScore of 60/100 reflects solid quantitative fundamentals. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of MDXL?
Yes, most major brokerages offer fractional shares of MediXall Group, Inc. (MDXL) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MDXL's earnings and financial reports?
MediXall Group, Inc. (MDXL) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for MDXL earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited financial data available for comprehensive analysis.
- OTC market investments carry higher risks.